+
Site Tour

EuroPCR 2022: Expand your mitral portfolio with Tendyne™

A short expert interview with Alison Duncan and Lenard Conradi discussing Tendyne™ and how it can optimize patient outcomes and support the patient peri-procedurely.

Related Videos

EuroPCR 2022: Mitral replacement

EuroPCR 2022: Leading clinical evidence

AV VALVES 2023: The Genesis of TEER

AV VALVES 2023: MR – MAC

AV VALVES 2023:HF and VHD – Patient Management

AV VALVES 2023: MR – Mixed MR

M-TEER: patient selection and current evidence

AV VALVES 2023:Decision Making in HF – Mitral

PCR LV 2021: Navitor™

EACVI Summit 2023: Congress symposium

TRENDING TOPICS

EACTS 2024 - Novel approaches for Valvular and LVAD therapies

Reconsidering current approaches to valve and LVAD therapies

Early outcomes on Epic Max platfrom

Cleveland clinic (US) experience: Early outcomes and a perspective on porcine vs. bovine

Webinar PFO closure in patients >60 Years

Webinar PFO closure with Amplatzer™ Talisman™ PFO Occluder in patients >60 years

CONNEXT


HUB
RELATED RESOURCES

PCRLV 2022: bRIGHT 30 days

ESC 2021: HF & VHD Guidelines

EuroEcho 2021: MR Treatment (Patient)

EXPAND Study: Data overview

CONNEXT


LIVE
RELATED EVENTS

AV VALVES 2023: Trending Topics – Complexity

SAFETY IS A JOURNEY | J. Van der Heyden & C. Besler

AV VALVES 2023: HoloLens Technology

AV VALVES 2023: TA, TF in TMVR

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline